North America Digital Pathology Market

North America Digital Pathology Market Size (2024 to 2029)

The North American Digital Pathology Market's size is estimated to be USD 393.77 million by 2029 from USD 222.44 million in 2024, growing at a CAGR of 12.10% during the forecast period. 

Digital pathology is managing data-based information and interpreting pathology information through digital slides in the environment.

MARKET DRIVERS

The rising investment in R&D, government support, and increasing adoption of digital imaging in the market are some factors driving the digital pathology market in North America.

The significant factors propelling the growth of the North American digital pathology market are increasing incidences of chronic diseases and accelerating initiatives by private and public organizations in diagnostics. Also, increasing the adoption rate and availability of digital pathology devices, end-user preference for digital pathology over conventional methods is likely to escalate the growth rate of the North American digital pathology market.

North America's digital pathology market is likely to grow rapidly over the forecast period, at a high rate of CAGR, owing to growth opportunities such as emerging economies of North American countries like the U.S. and Canada, which are contributing the majority of share to the market. Growing efforts by key market players to develop cost-efficient methodologies and pathology systems, the emergence of new market players due to the commercialization of the digital pathology market. Increasing applications of pathologies and consistently growing demand for enhanced technologies like multiple fiber optic communications, digital imaging, and robotic light microscopy are drawing more opportunities for the market's growth.

MARKET RESTRAINTS

Sampling errors, expensive systems, associated maintenance costs, lack of skilled professionals, and irregular reimbursement policies are significant challenges for the market to grow. In addition, older pathologists are reluctant to adopt new digital pathology techniques due to a lack of proper knowledge, further impeding the market's growth rate.

This research report on the North American digital pathology market has been segmented and sub-segmented into the following categories

North America Digital Pathology Market Analysis By Type

• Human Digital Pathology

• Animal Digital Pathology

North America Digital Pathology Market Analysis By Product

• Scanners

• Software

• Communication Systems

• Storage Systems

North America Digital Pathology Market Analysis By Application

• Teleconsultation

• Diseases Diagnosis

• Drug Discovery

• Training

• Education

North America Digital Pathology Market Analysis By End User

• Pharmaceutical Companies

• Hospitals

• Academic Institutions

North America Digital Pathology Market Analysis By Country 

• The United States

• Canada

• Rest of North America

Regional Analysis

North America accounted for the largest share of the global digital pathology market in 2022 and is estimated to continue its dominance during the forecast period. The U.S. Digital Pathology Market is predicted to dominate the North American market from 2023 to 2028. Also, the United States is North America's largest and fastest-growing market. Rising chronic diseases and technology in the U.S. will help to grow the digital pathology market. Digital pathology was started in the U.S., and U.S. food and drug administration announced the approval of Phillip's intelligible pathology solution to treat primary care. Also, USFDA approved to first slide imaging in 2017 for primary care in surgical pathology. The United States is the dominating segment in North America and the global market due to its not such strict regulatory policies, which are perceived as restraints in the case of other countries. Currently, digital pathology is widely used in North America owing to the vast number of companies in the market.

The Canadian digital pathology market is projected to grow at a healthy CAGR during the forecast period. The rising demand for digital pathology due to western culture in Canada is driving the market growth. Canadian companies focus on new slide imaging technology for patients' primary care and implementation of new technology with the help of government support. In 2018, a Canadian university (Kimia Lab) received massive investment from Ontario to fund research programs for its A.I. search engine.

KEY MARKET PLAYERS

Some of the major companies playing a leading role in the North American digital pathology market are Perkin Elmer, Inc., Definiens AG, Sectra AB, Koninklijke Philips N.V, G.E. Healthcare, Inspirata Co., Ventana Medical Systems, Inc., Leica Biosystems, 3D-Histech Ltd, Hamamatsu Photonics K.K., Digipath Co., ZEISS, Olympus Corporation, Quorum Technologies Inc. and Yokogawa Electronics Corporation.